Marshall Wace Llp Lowered Holding in Zoetis INC (ZTS) by $75.28 Million as Market Valuation Rose

May 17, 2018 - By Alfred Lee

Zoetis Inc. (NYSE:ZTS) LogoInvestors sentiment increased to 1.13 in 2017 Q4. Its up 0.03, from 1.1 in 2017Q3. It increased, as 34 investors sold ZTS shares while 251 reduced holdings. 80 funds opened positions while 241 raised stakes. 429.52 million shares or 2.55% less from 440.74 million shares in 2017Q3 were reported. First Manhattan reported 16,130 shares or 0.01% of all its holdings. Exxonmobil Tx reported 77,481 shares. Focused Wealth Mngmt invested in 200 shares. Proshare Advsrs Ltd accumulated 102,911 shares. Tiaa Cref Inv Management Limited Liability holds 0.27% or 5.65M shares in its portfolio. Hermes Limited holds 0.3% or 295,202 shares in its portfolio. Thrivent Financial For Lutherans owns 1.44M shares for 0.35% of their portfolio. Usca Ria Ltd Liability Corp holds 6,233 shares. Eqis Capital Management accumulated 5,480 shares. Bahl & Gaynor owns 20,951 shares. Moors & Cabot has invested 0.15% of its portfolio in Zoetis Inc. (NYSE:ZTS). Credit Suisse Ag invested in 705,904 shares. Wade G W & invested 0.04% of its portfolio in Zoetis Inc. (NYSE:ZTS). Hbk Limited Partnership has 191,254 shares for 0.13% of their portfolio. Meiji Yasuda Life Insur has invested 0.14% in Zoetis Inc. (NYSE:ZTS).

Since February 21, 2018, it had 0 buys, and 5 selling transactions for $7.23 million activity. $712,001 worth of Zoetis Inc. (NYSE:ZTS) was sold by Trawicki Roman. 32,000 shares valued at $2.60M were sold by PECK KRISTIN C on Wednesday, February 21. Lagano Roxanne sold 35,663 shares worth $2.89M.

Paul Marshall decreased its stake in Zoetis Inc (ZTS) by 46.35% based on its latest 2017Q4 regulatory filing with the SEC. Marshall Wace Llp sold 1.05 million shares as the company’s stock rose 13.71% while stock markets declined. The hedge fund run by Paul Marshall held 1.21M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $87.18 million, down from 2.26 million at the end of the previous reported quarter. Marshall Wace Llp who had been investing in Zoetis Inc for a number of months, seems to be less bullish one the $40.11B market cap company. The stock increased 0.06% or $0.05 during the last trading session, reaching $82.9. About 1.55M shares traded. Zoetis Inc. (NYSE:ZTS) has risen 51.68% since May 17, 2017 and is uptrending. It has outperformed by 40.13% the S&P500.

Marshall Wace Llp, which manages about $2.38B US Long portfolio, upped its stake in Icici Bank (NYSE:IBN) by 1.19 million shares to 2.83 million shares, valued at $27.52M in 2017Q4, according to the filing. It also increased its holding in A by 49,506 shares in the quarter, for a total of 142,734 shares, and has risen its stake in Vertex Pharm (NASDAQ:VRTX).

Analysts await Zoetis Inc. (NYSE:ZTS) to report earnings on August, 14. They expect $0.71 earnings per share, up 33.96 % or $0.18 from last year’s $0.53 per share. ZTS’s profit will be $343.54 million for 29.19 P/E if the $0.71 EPS becomes a reality. After $0.75 actual earnings per share reported by Zoetis Inc. for the previous quarter, Wall Street now forecasts -5.33 % negative EPS growth.

More notable recent Zoetis Inc. (NYSE:ZTS) news were published by: Themiddlemarket.com which released: “M&A daily wrap: NFL’s Carolina Panthers, Cam Newton, David Tepper, Appaloosa, Brynwood Partners” on May 16, 2018, also Benzinga.com with their article: “41 Biggest Movers From Yesterday” published on May 17, 2018, 247Wallst.com published: “Are Abaxis Shareholders Getting Enough in the Buyout?” on May 16, 2018. More interesting news about Zoetis Inc. (NYSE:ZTS) were released by: Nasdaq.com and their article: “Mid-Afternoon Market Update: Blink Charging Rises After Q1 Results; Purple Innovation Shares Slide” published on May 16, 2018 as well as Streetinsider.com‘s news article titled: “Zoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesn’t Change Thesis” with publication date: May 17, 2018.

Zoetis Inc. (NYSE:ZTS) Ratings Coverage

Among 13 analysts covering Zoetis (NYSE:ZTS), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. Zoetis had 18 analyst reports since November 24, 2017 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Tuesday, January 16. The stock of Zoetis Inc. (NYSE:ZTS) has “Hold” rating given on Thursday, April 19 by Hilliard Lyons. Craig Hallum maintained Zoetis Inc. (NYSE:ZTS) rating on Tuesday, January 2. Craig Hallum has “Buy” rating and $85.0 target. The firm has “Buy” rating by Citigroup given on Thursday, January 4. The firm earned “Buy” rating on Thursday, December 21 by Cantor Fitzgerald. UBS downgraded Zoetis Inc. (NYSE:ZTS) on Friday, November 24 to “Neutral” rating. The firm earned “Buy” rating on Thursday, February 15 by Stifel Nicolaus. The company was maintained on Friday, February 16 by Deutsche Bank. Craig Hallum maintained it with “Buy” rating and $9400 target in Wednesday, April 25 report. The company was maintained on Thursday, February 15 by Cowen & Co.

Zoetis Inc. (NYSE:ZTS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.